ANDREW JACKSON

Profile

First Name

: ANDREW

Middle Name

:

Last Name

: JACKSON

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
ALTHEADX, INC.
JEFFREY G. BLACK, FENG CAO, FRANCOIS FERRE, JORGE GARCES, JAMES GLAVIN, JAMES B GLAVIN, GREG HAMILTON, ANN KESSLER, DEVAL LASHKARI, DEVAL A LASHKARI, WEI LI, JASON LIU, J. MATTHEW MACKOWSKI, MAGDA MARQUET, JOSEPH MONFORTE, DAVID NIKODEM, CARIN SANDVIK, YUH-GENG TSAY, JOHN WU
EXECUTIVE OFFICER
RA MEDICAL SYSTEMS, INC.
MAURICE BUCHBINDER, MARTIN BURSTEIN, MELISSA BURSTEIN, JAMES CARUSO, VICKI CHESTER, MARTIN COLOMBATTO, BRIAN CONN, KEVIN GERTSMAN, RICHARD HEYMANN, DEAN IRWIN, DAVID A. JENKINS, JEFFREY KRAWS, JAMES B. LAUDENSLAGER, JONATHAN WILL MCGUIRE, WILL MCGUIRE, J. KEVIN MCVOY, RICHARD MEJIA, JR., SUSANNE MELINE, STEVEN PASSEY, WILLIAM L. SCHMIDT, JOAN STAFSLIEN
EXECUTIVE OFFICER
452 TALF FUND, LP
N/A 452 TALF SPV LLC, N/A HSBC GLOBAL ASSET MANAGEMENT (USA) INC., MATTHEW KIMBERLEY, JASON MOSHOS, CEDRIC TCHABAN, NICK VENTHAM
EXECUTIVE OFFICER
ETERNA THERAPEUTICS INC.
MATTHEW ANGEL, TERRY BATEMAN, JEFF BERG, KENDRA BERGER, BRANT BINDER, JAMES BRISTOL, BARRY CHANDLER, CHARLES CHERINGTON, PETER CICALA, DOROTHY CLARKE, KEVIN D-AMOUR, ERIN S. ENRIGHT, JOSEPH J. FARRICIELLI, JR., HOWARD J. FEDEROFF, GREGORY FIORE, SANDRA GURROLA, KENNETH L. KEYMER, VLADIMIR KHUCHUA-EDELMAN, DENNIS LANGER, MARY BETH LEWIS, SANJEEV LUTHER, STEVE MITGANG, ERICH MOHR, KIRK NAGAMINE, ELENA RATNER, HEATHER B. REDMAN, JAY SIAL, ROGER SIDHU, NICHOLAS J. SINGER, TONY UPHOFF, RICHARD W. WAGNER, WILLIAM WEXLER, PAUL YANOVER
EXECUTIVE OFFICER
CALIDI BIOTHERAPEUTICS, INC.
ALLAN CAMAISA, DAVID LAPRE, SCOTT LEFTWICH, BORIS MINEV, GEORGE NG, WENDY PIZARRO, JAMES A. SCHOENECK, ALAN R. STEWART
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-06-06
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2024-06-03 
2024-03-21
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2024-03-08 
2024-03-21
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2024-01-19 
2024-03-21
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2024-02-21 
2024-03-21
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2023-11-01 
2024-03-21
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2024-01-26 
2022-12-16
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-12-02 
2020-09-15
D
Link
OTHER INVESTMENT FUND 
 
 
 
2020-09-04 
2018-07-10
D
Link
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2016-08-30 
2018-06-18
D
Link
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
 
2018-06-04 
2018-06-13
D/A
Link
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2017-09-05 
2018-03-12
D
Link
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2018-02-23 
2017-02-14
D
Link
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2017-02-01